Dabur India Limited — FDA Class II (D-0632-2026)

Dabur India Limited is recalling 1,225 tubes of a drug due to CGMP deviations. This recall is classified as a Class II recall, indicating a temporary health risk. The recall affects products distributed in the United States.

• •Dabur India Limited is recalling 1,225 tubes of a drug.
• •The recall is due to CGMP deviations.
• •This is classified as a Class II recall.
• •Consumers should check for the recalled product.

Consumers who purchased this drug should check for the recalled 1,225 tubes. The recall is due to manufacturing issues that could affect safety.